NKX3.1 Antibody (YA4452)
(Synonyms: NKX3; BAPX2; NKX3A; NKX3.1; NKX3-1)NKX3.1 Antibody (YA4452) is a Mouse-derived and non-conjugated IgG2b monoclonal antibody, targeting to NKX3.1.
-
Host:
Mouse
-
Isotype:
IgG2b
-
Application:
WB, IHC-P, FC, ELISA
-
Reactivity :
Human
-
Formulation:
Supplied in PBS with 0.05% sodium azide.
-
Conjugation:
Non-conjugated
Applications
| Application |
WB
WB: Western Blot
|
IHC-P
IHC-P: Immunohistochemistry-Paraffin
|
FC
FC: Flow Cytometry
|
ELISA
ELISA: Enzyme Linked Immunosorbent Assay
|
|---|---|---|---|---|
| Dilution Ratio | 1:500-1:2000 | 1:200-1:1000 | 1:200-1:400 | 1:10000 |
Product Details
NKX3.1 Antibody (YA4452) is a Mouse-derived and non-conjugated IgG2b monoclonal antibody, targeting to NKX3.1.
-
Host Mouse
-
Clonality Monoclonal
-
Species ReactivityHuman
-
Observed Molecular WeightObserved band size: 26 kDaNote: Due to possible protein modifications or aggregation, the molecular weight should be confirmed by actual measurement, and the predicted value is for reference only.
-
Calculated Molecular Weight Predicted band size: 26 kDa
Purified recombinant fragment of human NKX3A full(aa 1-234).
affinity purified.
Non-conjugated
Unmodified
IgG2b
Product Properties
-
Appearance
Liquid
-
Formulation
Supplied in PBS with 0.05% sodium azide.
-
Storage & Stability
Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.
-
Shipping
Shipping with blue ice.
Background
-
Function
NKX3.1 transcription factor, which binds preferentially the consensus sequence 5'-TAAGT[AG]-3' and can behave as a transcriptional repressor. Plays an important role in normal prostate development, regulating proliferation of glandular epithelium and in the formation of ducts in prostate. Acts as a tumor suppressor controlling prostate carcinogenesis, as shown by the ability to inhibit proliferation and invasion activities of PC-3 prostate cancer cells
-
Subcellular Localization
Nucleus
-
Expression
Tissue_specificity:It is highly expressed in the prostate and at a lower level in the testes.
Induction:By androgens and, in the LNCaP cell line, by estrogens. Androgenic control may be lost in prostate cancer cells during tumor progression from an androgen-dependent to an androgen-independent phase -
Isoforms & Post-Translational Modification
Q99801 has 5 isomers: Q99801-1: 26350 Da (predicted); Q99801-2: 21099 Da (predicted); Q99801-3: 18423 Da (predicted); Q99801-4: 19049 Da (predicted); Q99801-5: 21626 Da (predicted).
Ubiquitinated by TOPORS; monoubiquitinated at several residues and also polyubiquitinated on single residues -
Subunit
Interacts with serum response factor (SRF) (By similarity). Interacts with SPDEF (PubMed:11809674). Interacts with WDR77 (PubMed:12972618). Interacts with TOPORS which polyubiquitinates NKX3-1 and induces its proteasomal degradation (PubMed:18077445). Interacts with FEM1B (By similarity)
-
SwissProt ID
-
Synonyms
NKX3; BAPX2; NKX3A; NKX3.1; NKX3-1
Documentation